In this video, Jeanne Palmer, MD, Mayo Clinic, Phoenix, AZ, gives an overview of promising agents being investigated for the treatment of myelofibrosis (MF) with cytopenia, including pacritinib, momelotinib, and luspatercept. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.